Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01740076 · ClinicalTrials.gov registry record · NA

Soy Nuts and Cardiovascular Risk in Postmenopausal Women

A NA study of Postmenopausal Women, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT01740076: Completed NA study of Postmenopausal Women, sponsored by Beth Israel Deaconess Medical Center.

NCT01740076 is a NA study of Postmenopausal Women that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 84 participants, roughly in line with the 80-participant average among 4 other Postmenopausal Women trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01740076, a NA study of Postmenopausal Women, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

To determine the effect of a whole soy food, dietary soy nuts, on blood pressure, lipid levels, inflammation and menopausal symptoms in postmenopausal women.

Primary Outcome

stratified by hypertensive status (normal BP, prehypertension, hypertension)

Conditions Studied

Interventions

  • OTHER soy nuts

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2001-09
Est. Completion 2012-11
Phase NA

What the finished NCT01740076 record still lists

NCT01740076 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, roughly in line with the 80-participant average among 4 other Postmenopausal Women trials with a reported enrollment target.

The record links to 1 condition, with Postmenopausal Women appearing as the primary indexed condition, and to 1 intervention - of which soy nuts is the first listed.

NCT01740076 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01740076 about?

NCT01740076 is a clinical study titled "Soy Nuts and Cardiovascular Risk in Postmenopausal Women". To determine the effect of a whole soy food, dietary soy nuts, on blood pressure, lipid levels, inflammation and menopausal symptoms in postmenopausal women.

What is the current status of trial NCT01740076?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2001-09. Estimated completion is 2012-11.

What conditions does trial NCT01740076 study?

This clinical trial studies the following conditions: Postmenopausal Women.

What interventions are being tested in trial NCT01740076?

The interventions under investigation include: soy nuts (OTHER).

Who is sponsoring clinical trial NCT01740076?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01740076 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postmenopausal Women

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01740076, the US trial registry maintained by the National Library of Medicine. NCT01740076 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.